Cargando…

Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden

Skin melanoma cells are tightly interconnected with their tumor microenvironment (TME), which influences their initiation, progression, and sensitivity/resistance to therapeutic interventions. An immune-active TME favors patient response to immune checkpoint inhibition (ICI), but not all patients re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Georgoulias, George, Zaravinos, Apostolos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650672/ https://www.ncbi.nlm.nih.gov/pubmed/36389735 http://dx.doi.org/10.3389/fimmu.2022.1006665

Ejemplares similares

Distinct genomic features across cytolytic subgroups in skin melanoma
por: Roufas, Constantinos, et al.
Publicado: (2021)

The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
por: Moeckel, Camille, et al.
Publicado: (2023)

Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
por: Vryza, Paraskevi, et al.
Publicado: (2023)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

Whole Genome Expression Microarray Analysis of Highly Versus Poorly Tumorigenic Murine Melanoma Cell Lines Provides Insights into Factors That Regulate Tumor Growth, Metastasis, and Immunogenicity
por: Hargadon, Kristian Michael
Publicado: (2015)

Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment
por: Ren, Jie, et al.
Publicado: (2022)

Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space
por: Ogishi, Masato, et al.
Publicado: (2019)

Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
por: Chen, Hao, et al.
Publicado: (2019)

The modulation of Dicer regulates tumor immunogenicity in melanoma
por: Hoffend, Nicholas C., et al.
Publicado: (2016)

Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
por: Chen, Hao, et al.
Publicado: (2019)

The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma
por: Zhang, Yan, et al.
Publicado: (2019)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

Fractal Dimensions of In Vitro Tumor Cell Proliferation
por: Lambrou, George I., et al.
Publicado: (2015)

Chromomycin A(5) induces bona fide immunogenic cell death in melanoma
por: Florêncio, Katharine Gurgel Dias, et al.
Publicado: (2022)

Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021)

The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
por: Cessna, Hannah, et al.
Publicado: (2022)

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma
por: Murata, Kenji, et al.
Publicado: (2020)

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
por: Chalmers, Zachary R., et al.
Publicado: (2017)

CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
por: Yang, Jingrun, et al.
Publicado: (2022)

Special Issue “Latest Review Papers in Molecular Genetics and Genomics 2023”
por: Zaravinos, Apostolos
Publicado: (2023)

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
por: Wen, Xiang-mei, et al.
Publicado: (2021)

Editorial: Mutational signatures and immune response in cancer
por: Georgakopoulos-Soares, Ilias, et al.
Publicado: (2023)

Co-Deregulated miRNA Signatures in Childhood Central Nervous System Tumors: In Search for Common Tumor miRNA-Related Mechanics
por: Lambrou, George I., et al.
Publicado: (2021)

Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity
por: Sivelle, Coline, et al.
Publicado: (2023)

The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study
por: Punta, Marco, et al.
Publicado: (2020)

Genome Replication Is Associated With Release of Immunogenic DNA Waste
por: Schubert, Nadja, et al.
Publicado: (2022)

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
por: Zaravinos, Apostolos, et al.
Publicado: (2019)

Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma
por: Guo, Hanyao, et al.
Publicado: (2023)

The Non-Coding RNA GAS5 and Its Role in Tumor Therapy-Induced Resistance
por: Lambrou, George I., et al.
Publicado: (2020)

RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
por: Zaravinos, Apostolos, et al.
Publicado: (2018)

Research progress in inducing immunogenic cell death of tumor cells
por: Xie, Deqian, et al.
Publicado: (2022)

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer
por: Luo, Yulou, et al.
Publicado: (2023)

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data
por: Li, Mengyuan, et al.
Publicado: (2023)

Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects
por: Soni, Chetna, et al.
Publicado: (2019)

Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization
por: Thornlow, Dana N., et al.
Publicado: (2021)

Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer
por: Mastrogamvraki, Natalia, et al.
Publicado: (2020)

Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer
por: Chatziantoniou, Angeliki, et al.
Publicado: (2022)

Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas
por: Wang, Mona Meng, et al.
Publicado: (2023)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
por: Yan, Junya, et al.
Publicado: (2020)

Landscape of Infiltrated Immune Cell Characterization in Uveal Melanoma to Improve Immune Checkpoint Blockade Therapy
por: Lv, Xiaohui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lv2lnntvkdpf1kakaf7nvu3a3e